BGE-102

N/A

Report date: 2026/04/08 15:41:56
NME

Base Information

Drug NameBGE-102
Drug Alias NameBGE-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsObesityNeuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioAge Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioAge Labs Inc
Inactive CompaniesN/A
Active IndicationsObesityNeuritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A